Alladapt Immunotherapeutics

Alladapt Immunotherapeutics is a private biopharmaceutical company developing prescription therapies for food allergies. The company’s lead program, ADP101, is being advanced as a broad-spectrum oral immunotherapy to alleviate food allergies triggered by single or multiple proteins from common allergens.